Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of DEPREXIL Treatment in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment

NCT06496087 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT06496087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06496087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of DEPREXIL Treatment in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment
Lead sponsor
Catalysis SL
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2022
Completion date
April 15, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depression mild, depression moderate, post-covid-19 syndrome